Allison David D. 4
4 · IPI Legacy Liquidation Co · Filed Apr 9, 2024
Insider Transaction Report
Form 4
Allison David D.
Director
Transactions
- Other
Stock Option (right to buy)
2024-04-05−13,222→ 0 totalExercise: $1.34Exp: 2033-06-15→ Common Stock (13,222 underlying) - Other
Stock Option (right to buy)
2024-04-05−12,789→ 0 totalExercise: $8.65Exp: 2032-06-15→ Common Stock (12,789 underlying) - Other
Stock Option (right to buy)
2024-04-05−11,500→ 0 totalExercise: $9.96Exp: 2031-07-10→ Common Stock (11,500 underlying)
Footnotes (3)
- [F1]Pursuant to the First Amended Joint Plan of Liquidation of Impel Pharmaceuticals Inc., which was confirmed by the United States Bankruptcy Court for the Northern District of Texas on April 2, 2024, all of the Issuer's shares of its capital stock were canceled and extinguished effective April 5, 2024, and any rights of any holder in respect thereof were canceled without any recovery.
- [F2]The option was fully vested.
- [F3]The option was scheduled to vest in full as of June 16, 2024.